Chromium (III) acetate

Chromium (III) acetate (Chromic acetate) is an AMPK inhibitor that promotes lipogenesis by inhibiting AMPK phosphorylation. Chromium (III) acetate has low toxicity in mammals, with an LD50 of 2365 mg/kg in rats[1][2].

Product Specifications

CAS Number

[1066-30-4]

Product Name Alternative

Chromium acetate; Chromic acetate; Chromium triacetate

UNSPSC

12352300

Hazard Statement

H302, H315, H317, H319, H332, H335, H373

Target

AMPK

Type

Reference compound

Related Pathways

Epigenetics; PI3K/Akt/mTOR

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/chromium-iii-acetate.html

Purity

99.9

Solubility

DMSO : 14.29 mg/mL (ultrasonic)

Smiles

C[Cr](C)C.O=C=O.O=C=O.O=C=O

Molecular Formula

C6H9CrO6

Molecular Weight

229.13

Precautions

H302, H315, H317, H319, H332, H335, H373

References & Citations

[1]Mahsa Baghban Salehi, et al. Rheological and transport properties of sulfonated polyacrylamide hydrogels for water shutoff in porous media. Polym. Adv. Technol. 2014, 25 396-405.|[2]Kim J, et al. Chromium acetate stimulates adipogenesis through regulation of gene expression and phosphorylation of adenosine monophosphate-activated protein kinase in bovine intramuscular or subcutaneous adipocytes[J]. Asian-Australasian journal of animal sciences, 2020, 33 (4) : 651.